Aclarion (ACON) News Today $0.11 +0.01 (+9.76%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Aclarion (NASDAQ:ACON) Receives Hold Rating from Maxim GroupDecember 15 at 1:38 AM | americanbankingnews.comMaxim Group Downgrades Aclarion (ACON)December 14, 2024 | msn.comAclarion announces Nociscan featured RSNA Edition of MAGNETOM FlashNovember 21, 2024 | markets.businessinsider.comAclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM FlashNovember 21, 2024 | globenewswire.comAclarion files to sell 27.52M shares of common stock for holdersNovember 5, 2024 | markets.businessinsider.comAclarion files to sell 20M shares of common stock for holdersOctober 25, 2024 | markets.businessinsider.comAclarion to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 10, 2024 | globenewswire.comAclarion’s Nociscan Technology Enhances Understanding of Modic Changes in Back Pain PatientsSeptember 30, 2024 | msn.comAclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesSeptember 27, 2024 | globenewswire.comPRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI TechnologySeptember 13, 2024 | globenewswire.comAclarion, Inc.: Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesSeptember 12, 2024 | finanznachrichten.deAclarion Provides Corporate Update on Nociscan AI Technology MilestonesSeptember 12, 2024 | globenewswire.comAclarion, Inc.: Aclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialSeptember 10, 2024 | finanznachrichten.deAclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialSeptember 10, 2024 | globenewswire.comAclarion Added to PRISM Emerging Medical Devices IndexSeptember 6, 2024 | globenewswire.comAclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation MarketSeptember 5, 2024 | markets.businessinsider.comAclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation MarketSeptember 5, 2024 | globenewswire.comAclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New JerseyAugust 29, 2024 | globenewswire.comMicron To $140? Here Are 10 Top Analyst Forecasts For MondayAugust 28, 2024 | msn.comMaxim Group Remains a Buy on Aclarion, Inc. (ACON)August 23, 2024 | markets.businessinsider.comAclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment PlansAugust 21, 2024 | globenewswire.comAclarion to Present at August 20th Virtual Investor Summit Microcap EventAugust 15, 2024 | globenewswire.comAclarion Announces First Commercial Agreement in MichiganAugust 14, 2024 | globenewswire.comAclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UKAugust 13, 2024 | globenewswire.comAscendiant Capital Initiates Coverage of Aclarion (ACON) with Buy RecommendationJuly 31, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Aclarion, Inc. (ACON), Edwards Lifesciences (EW) and Sanofi (OtherSNYNF)July 29, 2024 | markets.businessinsider.comAclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UKJuly 9, 2024 | globenewswire.comAclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UKJune 26, 2024 | globenewswire.comAclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonJune 25, 2024 | globenewswire.comACON Stock Earnings: Aclarion Reported Results for Q1 2024May 16, 2024 | msn.comAclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainApril 25, 2024 | globenewswire.comAclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 23, 2024 | finance.yahoo.comWhy Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionApril 2, 2024 | benzinga.comAclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsMarch 4, 2024 | finance.yahoo.comAclarion Announces Closing of $3.0 Million Public OfferingFebruary 27, 2024 | globenewswire.comWhy Aclarion (ACON) Shares Are Down Over 60% TodayFebruary 26, 2024 | msn.comAclarion Announces Pricing of $3.0 Million Public OfferingFebruary 26, 2024 | globenewswire.comWhy Is Aclarion (ACON) Stock Down 19% Today?February 26, 2024 | investorplace.comWhy Is Aclarion (ACON) Stock Down 19% Today?February 26, 2024 | investorplace.comAclarion Stock (NASDAQ:ACON), Short Interest ReportFebruary 1, 2024 | benzinga.comAclarion Stock (NASDAQ:ACON) Dividends: History, Yield and DatesJanuary 30, 2024 | benzinga.comEQS-News: Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDJanuary 22, 2024 | markets.businessinsider.comAclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDJanuary 22, 2024 | markets.businessinsider.comTrading was temporarily halted for "ACON" at 09:01 AM with a stated reason of "LULD pause."January 8, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 11:01 AM with a stated reason of "LULD pause."January 5, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 10:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 10:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 09:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 07:01 PM with a stated reason of "News pending."January 4, 2024 | marketbeat.comACLARION INC. DL-,00001 (IT2.BE)January 3, 2024 | ca.finance.yahoo.com Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address DeFi Coin on Verge of Breakout! (Ad)[FREE BOOK] Can You Make a Fortune in Crypto with $50? Get started now before the market takes off! Click here to request your free copy NOW! ACON Media Mentions By Week ACON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACON News Sentiment▼0.470.75▲Average Medical News Sentiment ACON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACON Articles This Week▼31▲ACON Articles Average Week Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ATI Physical Therapy News Today CareMax News Today IMAC News Today NewGenIvf Group News Today Better Therapeutics News Today Aclarion News Today American Oncology Network News Today Global Cord Blood News Today LifeMD News Today Ontrak News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACON) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
